Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome
Top Cited Papers
- 1 December 2002
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 161 (6), 1991-1996
- https://doi.org/10.1016/s0002-9440(10)64476-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical EndpointsThe American Journal of Pathology, 2001
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and ImmunohistochemistryLaboratory Investigation, 2001
- Molecular portraits of human breast tumoursNature, 2000
- Tissue microarrays for gene amplification surveys in many different tumor types.1999
- GATA-3 is expressed in association with estrogen receptor in breast cancerInternational Journal of Cancer, 1999
- Making and reading microarraysNature Genetics, 1999
- College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee.1995
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCERThe Lancet, 1987